1-109715192-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000851.4(GSTM5):c.519G>C(p.Lys173Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00246 in 1,614,196 control chromosomes in the GnomAD database, including 135 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 127 hom. )
Consequence
GSTM5
NM_000851.4 missense
NM_000851.4 missense
Scores
12
Clinical Significance
Conservation
PhyloP100: 0.400
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.006391436).
BP6
?
Variant 1-109715192-G-C is Benign according to our data. Variant chr1-109715192-G-C is described in ClinVar as [Benign]. Clinvar id is 779857.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0622 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSTM5 | NM_000851.4 | c.519G>C | p.Lys173Asn | missense_variant | 7/8 | ENST00000256593.8 | |
GSTM5 | XM_005270784.5 | c.519G>C | p.Lys173Asn | missense_variant | 8/9 | ||
GSTM5 | XM_005270785.5 | c.207G>C | p.Lys69Asn | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSTM5 | ENST00000256593.8 | c.519G>C | p.Lys173Asn | missense_variant | 7/8 | 1 | NM_000851.4 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.00284 AC: 432AN: 152190Hom.: 8 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
432
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00598 AC: 1504AN: 251496Hom.: 64 AF XY: 0.00530 AC XY: 721AN XY: 135922
GnomAD3 exomes
AF:
AC:
1504
AN:
251496
Hom.:
AF XY:
AC XY:
721
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00241 AC: 3530AN: 1461888Hom.: 127 Cov.: 31 AF XY: 0.00232 AC XY: 1685AN XY: 727246
GnomAD4 exome
AF:
AC:
3530
AN:
1461888
Hom.:
Cov.:
31
AF XY:
AC XY:
1685
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00286 AC: 436AN: 152308Hom.: 8 Cov.: 33 AF XY: 0.00314 AC XY: 234AN XY: 74482
GnomAD4 genome
?
AF:
AC:
436
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
234
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
?
AF:
AC:
712
Asia WGS
AF:
AC:
127
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Benign
T
Polyphen
0.0010
.;B;.
Vest4
0.40, 0.43
MutPred
Loss of methylation at K173 (P = 0.004);Loss of methylation at K173 (P = 0.004);Loss of methylation at K173 (P = 0.004);
MVP
0.076
MPC
0.14
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at